• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Senores Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 93477.0
  • ISIN : INE0RB801010
665.35 -24 (-3.42%)
  • As on 03 Aug 2025 (EOD)
  • Today’s Low

    660.00
  • Today’s High

    694.35
  • Open

    689.10
  • Perv Close

    688.90
  • 52W Low

    435.25
  • 52W High

    719.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,064.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    153.73

  • Debt-Equity Ratio

    -3.42

  • AGM Date

    01-Aug-2025

  • EPS

    1.32

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    3,064.18

  • RONW (%)

    26.19

  • ROCE (%)

    12.04

Score Board

  • Equity (₹ in Cr.)

    46.05

  • BV (₹)

    153.70

  • Sales( ₹ in Cr.)

    38.54

  • NP (in Cr.)

    3.69

  • NP Var(%)

    354.0

  • Div%

    0.0

  • CPS (₹)

    1.50

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    3,069.70

  • 52 Week High

    719.00

  • 52 Week Low

    435.25

  • Price BSE

    667.0

  • Price NSE

    665.00

  • Market Capital( in Cr.)

    3,069.70

  • P/C Ratio

    453.70

  • P/E Ratio

    832.50

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 34.01 12.38 13.54 7.91 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 34.01 12.38 13.54 7.91 - -
Other Income 6.85 6.79 0.94 0.15 - -
Stock Adjustments 0.39 0.48 2.40 -0.05 - -
Total Income 41.25 19.65 16.88 8.01 - -
EXPENDITURE :            
Raw Materials 19.73 6.35 10.60 3.94 - -
Power and Fuel Cost 0.31 0.00 0.00 0.03 - -
Employee Cost 9.35 5.02 2.86 1.63 - -
Other Manufacturing Expenses 1.04 0.05 0.04 0.76 - -
Selling and Administration Expenses 3.41 2.96 1.28 0.35 - -
Miscellaneous Expenses 0.62 0.26 0.00 0.14 - -
Employee Benefit Expenses 9.35 5.02 2.86 1.63 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 34.45 14.65 14.79 6.84 - -
Operating Profit 6.78 5.01 2.10 1.17 - -
Interest 2.71 2.14 0.56 0.20 - -
Gross Profit 4.07 2.87 1.54 0.97 - -
Depreciation 2.04 0.93 0.71 0.57 - -
Profit Before Tax 2.03 1.94 0.83 0.40 - -
Current Tax 1.36 0.35 0.17 0.01 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.14 0.39 -0.02 -0.45 - -
Reported Net Profit 0.81 1.20 0.68 0.84 - -
Extraordinary Items 0.00 0.00 0.00 0.00 - -
Adjusted Net Profit 0.81 1.20 0.68 0.84 - -
Adjustment below Net Profit 0.00 0.00 0.00 0.00 - -
P & L Balance brought forward 2.57 1.37 0.69 0.34 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 3.39 2.57 1.37 1.18 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 0.27 1.22 0.78 2.20 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 55.11 39.66 38.54 24.91 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    45.78%

  • Public Share Holding

    54.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 2,579,940 5.60 2,579,940 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 330,000 330,000.00 330,000 330,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,909,940 6.32 2,909,940 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,963,963 12.95 5,963,963 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,715,176 25.44 11,715,176 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,174,139 39.46 18,174,139 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,688,191 3.67 1,688,191 20
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,866,968 4.05 1,866,968 2
Mutual Funds / UTI 1,380,596 3.00 1,380,596 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,131,444 2.46 1,131,444 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,067,199 13.17 6,067,199 40
2] Non Institution
Bodies Corporate 1,635,813 3.55 1,635,813 230
Clearing Members 1,068 0.00 1,068 1
Directors of their Relatives 20,000 0.04 20,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 364,253 0.79 364,253 421
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,014,606 4.37 2,014,606 1,070
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,963,240 17.29 7,963,240 78
Individuals holding nominal share capital up to Rs. 1 lakh 6,517,850 14.15 6,517,850 34,490
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 979 0.00 979 2
Others 200,000 0.43 200,000 1
Sub Total 18,902,310 41.04 18,902,310 36,333
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 46,053,588 100.00 46,053,588 36,389

Company Background

Senores Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Senores Pharmaceuticals Ltd
  • BSE Code : 93477.0
  • ISIN : INE0RB801010
  • Incorporation Year

    2017

  • Registered Office

    #.1101-1103 11th Flr South Twr
    Ambali Bopal Road, Ahmedabad,
    Gujarat-380054

  • Telephone

    +91-79-2999 9857

  • FAX

  • Chairman

    Sanjay Majmudar

  • Managing Director

    SWAPNIL JATINBHAI SHAH

  • Company Secretary

    Nidhi Dilipbhai Kapadia

  • Auditor

    Pankaj R Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Senores Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Senores Pharma. 666.55 40.85 34.01 504.96 2.56
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10